Artificial intelligence (AI) offers the potential to transform drug discovery. Over the last few years, AI-enabled drug discovery has grown substantially through technological progress, such as the use of neural networks to design molecules and the application of knowledge graphs to understand target biology.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Competing Interests
The authors of this article are employees of The Boston Consulting Group (BCG), a management consultancy that works with the world's leading biopharmaceutical companies. The research for this specific article was funded by BCG's Health Care practice.
